Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lime Technologies AB (PUBL) | 278,560 | net | 17 Jun 2022 | tx 12+293,560−15,000 |
| NeuroVive Pharmaceutical AB | -121,768 | net | 07 Feb 2025 | tx 13+5,876,257−5,998,025 |
| Beammwave AB (publ) | 63,090 | net | 09 Mar 2022 | tx 2+63,090 |
| Karnov Group AB (publ) | 18,360 | net | 12 Feb 2026 | tx 3+18,360 |
| Acconeer AB | 1,154 | net | 15 Dec 2021 | tx 4+6,927−5,773 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | PURCHASE | Karnov Group AB (publ) | 7,500 | 65.67 SEK | |
| 21 May 2025 | PURCHASE | Karnov Group AB (publ) | 4,706 | 88.00 SEK | |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 2,000,000 | 0.05 SEK | deriv |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 3,000,000 | 0.03 SEK | deriv |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 998,025 | 0.45 SEK | |
| 28 Jun 2024 | PURCHASE | Karnov Group AB (publ) | 6,154 | 70.50 SEK | |
| 30 May 2024 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 2,000,000 | 0.03 SEK | deriv |
| 17 Apr 2024 | PURCHASE | NeuroVive Pharmaceutical AB | 213,861 | 0.16 SEK | first after silence |
| 20 Mar 2023 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 3,000,000 | 0.06 SEK | deriv |
| 27 Jun 2022 | PURCHASE | NeuroVive Pharmaceutical AB | 210,416 | 0.35 SEK | |
| 17 Jun 2022 | PURCHASE | Lime Technologies AB (PUBL) | 68,160 | 0.00 SEK | deriv |
| 09 Mar 2022 | GRANT_AWARD | Beammwave AB (publ) | 31,545 | 15.85 SEK | |
| 09 Mar 2022 | GRANT_AWARD | Beammwave AB (publ) | 31,545 | 0.00 SEK | deriv |
| 15 Dec 2021 | PURCHASE | Acconeer AB | 577 | 60.00 SEK | |
| 21 May 2021 | PURCHASE | NeuroVive Pharmaceutical AB | 69,108 | 0.72 SEK | |
| 07 May 2021 | PURCHASE | Acconeer AB | 5,773 | 40.47 SEK | first after silence |
| 07 May 2021 | SALE | Acconeer AB | 5,773 | 40.00 SEK | |
| 20 Jul 2020 | SALE | Lime Technologies AB (PUBL) | 15,000 | 300.04 SEK | |
| 29 Apr 2020 | PURCHASE | NeuroVive Pharmaceutical AB | 126,199 | 0.80 SEK | first after silence |
| 01 Mar 2019 | OTHER | Lime Technologies AB (PUBL) | 23,010 | 5.48 SEK | |
| 01 Mar 2019 | OTHER | Lime Technologies AB (PUBL) | 51,484 | 21.08 SEK | |
| 06 Feb 2019 | PURCHASE | NeuroVive Pharmaceutical AB | 206,673 | 1.35 SEK | |
| 19 Dec 2018 | PURCHASE | NeuroVive Pharmaceutical AB | 20,000 | 1.31 SEK | |
| 06 Dec 2018 | PURCHASE | Lime Technologies AB (PUBL) | 1,400 | 72.00 SEK | first after silence |
| 24 Apr 2018 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 20,000 | 8.00 SEK |
4 purchases reported after at least 12 months of silence — most recent on 17 Apr 2024.